What Happened?
South San Francisco, CA-based Federation-Bio Appointed Emily Conley as Chief Executive Officer
About the Company
Federation Bio is a biotechnology company pioneering a novel approach to create potent, durable and safe cell therapies. The company`s first-in-class platform combines the power of genetic engineering and synthetic consortium design to control systemic immune responses and broad metabolic functions. Federation Bio`s pipeline addresses a range of serious illnesses from metabolic disorders to metastatic cancer. The company`s lead program is in enteric hyperoxaluria, a serious renal condition that affects more than 250,000 Americans and for which there are currently no approved therapies.
About the Person
Emily Conley is Chief Executive Officer at Federation Bio. Previously, Emily held various senior HR leadership roles in the industry.
Info Source
News
Short Profile